Drug Shortage Report for RANITIDINE INJECTION USP
| Report ID | 93458 |
| Drug Identification Number | 02256711 |
| Brand name | RANITIDINE INJECTION USP |
| Common or Proper name | RANITIDINE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 50ml |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-08-19 |
| Estimated end date | 2020-06-12 |
| Actual end date | 2020-06-12 |
| Shortage status | Resolved |
| Updated date | 2020-06-22 |
| Company comments | Product released Tuesday February 4th 2020 and available under a protective allocation at 200% of historical monthly volumes at this time. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-09-10 | French | Compare |
| v1 | 2019-09-10 | English | Compare |